Other antineoplastic agents

• L01XA: Platinum compounds
• L01XB: Methylhydrazines
• L01XC: Monoclonal antibodies
• L01XD: Sensitizers used in photodynamic/radiation therapy
• L01XF: Retinoids for cancer treatment
• L01XG: Proteasome inhibitors
• L01XH: Histone deacetylase (HDAC) inhibitors
• L01XJ: Hedgehog pathway inhibitors
• L01XK: Poly (ADP-ribose) polymerase (PARP) inhibitors
• L01XL05: ciltacabtagene autoleucel
• L01XL06: brexucabtagene autoleucel
• L01XL07: idecabtagene vicleucel
• L01XX: Other antineoplastic agents
• L01XY: Combinations of antineoplastic agents

NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Other antineoplastic agents/adverse effects"[Mesh] OR "Other antineoplastic agents/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])